Biomea Fusion BMEA
NASDAQ BMEA
$1.37 +0.01 (+0.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Total Non-Current Liabilities (2024 - 2026)

Biomea Fusion (BMEA) posted Total Non-Current Liabilities of $9.3 million for Q1 2026, down 17.23% sequentially from $11.2 million in Q4 2025.

Biomea Fusion (BMEA) Total Non-Current Liabilities (2024 - 2026) Analysis & Trends

Biomea Fusion has reported Total Non-Current Liabilities for 3 years, with the latest figure at $9.3 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities changed N/A year-over-year to $9.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.3 million (changed N/A YoY) and the FY2025 annual result came in at $11.2 million, down 60.41% from the prior year.
  • Total Non-Current Liabilities slipped to $9.3 million in Q1 2026 per BMEA's latest filing, from $11.2 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $28.4 million in Q4 2024 and troughed at $9.3 million in Q1 2026.
  • A 3-year average of $18.9 million and a median of $21.7 million in 2025 frame the typical range for Total Non-Current Liabilities.
  • The widest YoY moves for Total Non-Current Liabilities: up 60.41% in 2025, down 60.41% in 2025.
  • Over 3 years, Total Non-Current Liabilities stood at $28.4 million in 2024, then slumped by 60.41% to $11.2 million in 2025, then fell by 17.23% to $9.3 million in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $9.3 million, $11.2 million, and $21.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 5.92 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 7.74 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 40.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 3.92 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.88 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 4.20 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 724.15 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.17 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 9.32 Bn
10 Biomea Fusion 97.69 Mn 97.69 Mn - 10.44 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 10.48 Mn
Mar 31, 2026 9.29 Mn
Dec 31, 2025 11.23 Mn
Sep 30, 2025 21.65 Mn
Jun 30, 2025 23.87 Mn
Dec 31, 2024 28.37 Mn